Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


A Patient with Congenital Generalized Lipodystrophy Due To a Novel Mutation in BSCL2: Indications for Secondary Mitochondrial Dysfunction.

Jeninga EH, de Vroede M, Hamers N, Breur JM, Verhoeven-Duif NM, Berger R, Kalkhoven E.

JIMD Rep. 2012;4:47-54. doi: 10.1007/8904_2011_86. Epub 2011 Nov 4.


Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis.

Fernandez-Marcos PJ, Jeninga EH, Canto C, Harach T, de Boer VC, Andreux P, Moullan N, Pirinen E, Yamamoto H, Houten SM, Schoonjans K, Auwerx J.

Sci Rep. 2012;2:425. doi: 10.1038/srep00425. Epub 2012 May 28.


The metabolic footprint of aging in mice.

Houtkooper RH, Argmann C, Houten SM, Cantó C, Jeninga EH, Andreux PA, Thomas C, Doenlen R, Schoonjans K, Auwerx J.

Sci Rep. 2011;1:134. doi: 10.1038/srep00134. Epub 2011 Oct 31.


Central players in inherited lipodystrophies.

Jeninga EH, Kalkhoven E.

Trends Endocrinol Metab. 2010 Oct;21(10):581-8. doi: 10.1016/j.tem.2010.06.006. Epub 2010 Jul 10.


Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility.

Jeninga EH, Schoonjans K, Auwerx J.

Oncogene. 2010 Aug 19;29(33):4617-24. doi: 10.1038/onc.2010.206. Epub 2010 Jun 7. Review.


Functional implications of genetic variation in human PPARgamma.

Jeninga EH, Gurnell M, Kalkhoven E.

Trends Endocrinol Metab. 2009 Oct;20(8):380-7. doi: 10.1016/j.tem.2009.04.005. Epub 2009 Sep 10. Review.


Peroxisome proliferator-activated receptor gamma regulates expression of the anti-lipolytic G-protein-coupled receptor 81 (GPR81/Gpr81).

Jeninga EH, Bugge A, Nielsen R, Kersten S, Hamers N, Dani C, Wabitsch M, Berger R, Stunnenberg HG, Mandrup S, Kalkhoven E.

J Biol Chem. 2009 Sep 25;284(39):26385-93. doi: 10.1074/jbc.M109.040741. Epub 2009 Jul 24.


The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation.

Dreijerink KM, Varier RA, van Beekum O, Jeninga EH, Höppener JW, Lips CJ, Kummer JA, Kalkhoven E, Timmers HT.

Mol Cell Biol. 2009 Sep;29(18):5060-9. doi: 10.1128/MCB.01001-08. Epub 2009 Jul 13.


Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.

Koppen A, Houtman R, Pijnenburg D, Jeninga EH, Ruijtenbeek R, Kalkhoven E.

Mol Cell Proteomics. 2009 Oct;8(10):2212-26. doi: 10.1074/mcp.M900209-MCP200. Epub 2009 Jul 10.


Impaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy.

Jeninga EH, van Beekum O, van Dijk AD, Hamers N, Hendriks-Stegeman BI, Bonvin AM, Berger R, Kalkhoven E.

Mol Endocrinol. 2007 May;21(5):1049-65. Epub 2007 Feb 20.


Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma.

Monajemi H, Zhang L, Li G, Jeninga EH, Cao H, Maas M, Brouwer CB, Kalkhoven E, Stroes E, Hegele RA, Leff T.

J Clin Endocrinol Metab. 2007 May;92(5):1606-12. Epub 2007 Feb 13.


Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing blood.

Remijn JA, Wu YP, Jeninga EH, IJsseldijk MJ, van Willigen G, de Groot PG, Sixma JJ, Nurden AT, Nurden P.

Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):686-91.


Supplemental Content

Loading ...
Support Center